EcoVadis Platinum Level Achieved in 2026
We have renewed our EcoVadis assessment and achieved the Platinum level!
What Are Polynucleotides?
Polynucleotides are long-chain biopolymers composed of nucleotide monomers, the building blocks of DNA. These molecules play a crucial role in cell communication, tissue repair, and skin regeneration. Due to their biocompatibility and ability to interact with cellular processes, polynucleotides have gained significant interest in biomedical research and clinical applications.
Mechanism of Action: How Polynucleotides Work?
Polynucleotides exert their effects primarily through:

Therapeutic Applications of Polynucleotides
Thanks to their regenerative and bio-stimulatory properties, polynucleotides are widely used in several medical fields:
Polynucleotides are used in injectables and topical treatments to enhance skin quality, reduce fine lines, and improve hydration. They are particularly effective in restoring skin elasticity and treating signs of aging.
Their ability to accelerate cell regeneration makes polynucleotides valuable in wound healing, post-surgical recovery, and scar treatment.
Polynucleotide-based therapies are being explored for treating dry eye syndrome and corneal injuries due to their anti-inflammatory and regenerative effects.
Polynucleotides contribute to the repair of tendons, cartilage, and ligaments, offering potential solutions for treating musculoskeletal injuries and osteoarthritis.
Sustainable and Safe Sourcing: Polynucleotides from wild salmon
At HTL Biotechnology, safety, efficacy and sustainability are at the heart of our commitments. Our polynucleotides are derived from wild salmon from Alaska, a region renowned for the purity of its waters and the absence of industrial pollution. These salmon thrive in a pristine natural environment, free from antibiotics, growth hormones or contaminants associated with intensive aquaculture.
In addition, the salmon used by HTL Biotechnology is caught as part of the food industry, making polynucleotide extraction a co-product of sustainable fishing practices. This ensures that no additional environmental burdens are created solely for the production of biopolymers.
Hyaluronic acid (HA) has become the dominant biomaterial in injectable soft tissue augmentation, with millions of treatments performed annually worldwide. As a naturally occurring glycosaminoglycan composed of repeating disaccharide units of D-glucuronic acid and N-acetyl-D-glucosamine, native HA possesses exceptional biocompatibility, hygroscopicity, and viscoelastic properties. However, in its unmodified state, HA is rapidly degraded in vivo by endogenous hyaluronidases and reactive oxygen species, with a tissue half-life measured in hours to days. [1,2]
To overcome this limitation and create materials suitable for lasting soft tissue correction, HA must be chemically cross-linked. This process transforms a fluid polysaccharide solution into a structured hydrogel with tuneable mechanical and biological properties. The chemistry of cross-linking is, in many respects, the defining step that determines how a dermal filler will perform in the hands of a clinician and in the tissues of a patient. [2,3]
On January 29, 2026, during IMCAS World Congress in Paris, HTL Biotechnology hosted its first scientific session dedicated to the future of regenerative and aesthetic medicine.
Bringing together experts from industry and clinical practice, the session explored how advanced biopolymers are helping shift aesthetic medicine toward a more regenerative approach, focused on skin quality, tissue repair, and long-term biological function.